Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use
暂无分享,去创建一个
Caroline Moermond | John Jensen | Birger Scholz | L. S. Nilssen | J. Jensen | S. Brendler-Schwaab | Rhys Whomsley | Susanne Brendler-Schwaab | Eadaoin Griffin | Laila Sortvik Nilssen | Henry Stemplewski | Ines Roennefahrt | B. Scholz | C. Moermond | R. Whomsley | H. Stemplewski | Ines Roennefahrt | E. Griffin
[1] M. Vighi,et al. Scientific Advice on Guidance Document n°27: Technical Guidance for Deriving Environmental Quality Standards , 2017 .
[2] E. V. Nieuwenhuyse. Understanding the Relationship between Extraction Technique and Bioavailability , 2013 .
[3] J. Santos,et al. Pharmaceutically active compounds in sludge stabilization treatments: anaerobic and aerobic digestion, wastewater stabilization ponds and composting. , 2015, The Science of the total environment.
[4] J. Santos,et al. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal. , 2012, Journal of hazardous materials.
[5] It Istituto Superiore di Sanit,et al. Common implementation strategy for the water framework directive (2000/60/EC). Guidance document on euthrophication assessment in the context of European water policies. (Technical report 2009-030; Guidance document 23) , 2009 .
[6] Guidance on information requirements and chemical safety assessment , 2008 .